{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:07:23Z","timestamp":1768842443941,"version":"3.49.0"},"posted":{"date-parts":[[2024,1,31]]},"group-title":"Microbiology","reference-count":53,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Ebola virus (EBOV) is a filamentous negative-sense RNA virus which causes severe hemorrhagic fever. There are limited vaccines or therapeutics for prevention and treatment of EBOV, so it is important to get a detailed understanding of the virus lifecycle to illuminate new drug targets. EBOV encodes for the matrix protein, VP40, which regulates assembly and budding of new virions from the inner leaflet of the host cell plasma membrane (PM). In this work we determine the effects of VP40 mutations altering electrostatics on PM interactions and subsequent budding. VP40 mutations that modify surface electrostatics affect viral assembly and budding by altering VP40 membrane binding capabilities. Mutations that increase VP40 net positive charge by one (e.g., Gly to Arg or Asp to Ala) increase VP40 affinity for phosphatidylserine (PS) and PI(4,5)P\n                  <jats:sub>2<\/jats:sub>\n                  in the host cell PM. This increased affinity enhances PM association and budding efficiency leading to more effective formation of virus-like particles (VLPs). In contrast, mutations that decrease net positive charge by one (e.g., Gly to Asp) lead to a decrease in assembly and budding because of decreased interactions with the anionic PM. Taken together our results highlight the sensitivity of slight electrostatic changes on the VP40 surface for assembly and budding. Understanding the effects of single amino acid substitutions on viral budding and assembly will be useful for explaining changes in the infectivity and virulence of different EBOV strains, VP40 variants that occur in nature, and for long-term drug discovery endeavors aimed at EBOV assembly and budding.\n                <\/jats:p>","DOI":"10.1101\/2024.01.30.578092","type":"posted-content","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T21:50:10Z","timestamp":1706737810000},"source":"Crossref","is-referenced-by-count":0,"title":["Minor changes in electrostatics robustly increase VP40 membrane binding, assembly, and budding of Ebola virus matrix protein derived virus-like particles"],"prefix":"10.64898","author":[{"given":"Balindile B.","family":"Motsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tej","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-4975","authenticated-orcid":false,"given":"Prem P.","family":"Chapagain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-7863","authenticated-orcid":false,"given":"Robert V.","family":"Stahelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024020302450426000_2024.01.30.578092v1.1","doi-asserted-by":"crossref","first-page":"e0001083","DOI":"10.1371\/journal.pgph.0001083","article-title":"The World Health Organization\u2019s disease outbreak news: A retrospective database","volume":"3","year":"2023","journal-title":"PLoS Glob. Public Health"},{"key":"2024020302450426000_2024.01.30.578092v1.2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40121-023-00913-y","article-title":"Navigating the complex landscape of ebola infection treatment: A review of emerging pharmacological approaches","volume":"13","year":"2024","journal-title":"Infect. Dis. Ther"},{"key":"2024020302450426000_2024.01.30.578092v1.3","doi-asserted-by":"crossref","first-page":"101339","DOI":"10.1016\/j.coviro.2023.101339","article-title":"A review of broadly protective monoclonal antibodies to treat Ebola virus disease","volume":"61","year":"2023","journal-title":"Curr. Opin. Virol"},{"key":"2024020302450426000_2024.01.30.578092v1.4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/vaccines9030190","article-title":"Development of pandemic vaccines: ERVEBO case study","volume":"9","year":"2021","journal-title":"Vaccines"},{"key":"2024020302450426000_2024.01.30.578092v1.5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14728222.2014.863877","article-title":"Could the Ebola virus matrix protein VP40 be a drug target?","volume":"18","year":"2014","journal-title":"Expert Opin. Ther. Targ"},{"key":"2024020302450426000_2024.01.30.578092v1.6","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10101330"},{"key":"2024020302450426000_2024.01.30.578092v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.12.003"},{"key":"2024020302450426000_2024.01.30.578092v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.07.015"},{"key":"2024020302450426000_2024.01.30.578092v1.9","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/JVI.79.3.1898-1905.2005","article-title":"VP40 Octamers Are Essential for Ebola Virus Replication J","volume":"79","year":"2005","journal-title":"Virol"},{"key":"2024020302450426000_2024.01.30.578092v1.10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01087-15"},{"key":"2024020302450426000_2024.01.30.578092v1.11","doi-asserted-by":"crossref","first-page":"e59225","DOI":"10.7554\/eLife.59225","article-title":"Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers","volume":"9","year":"2020","journal-title":"eLife"},{"key":"2024020302450426000_2024.01.30.578092v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/srep19125"},{"key":"2024020302450426000_2024.01.30.578092v1.13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.11.5205-5214.2001"},{"key":"2024020302450426000_2024.01.30.578092v1.14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00300"},{"key":"2024020302450426000_2024.01.30.578092v1.15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.10.4855-4865.2002"},{"key":"2024020302450426000_2024.01.30.578092v1.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020099"},{"key":"2024020302450426000_2024.01.30.578092v1.17","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-3-31"},{"key":"2024020302450426000_2024.01.30.578092v1.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001110"},{"key":"2024020302450426000_2024.01.30.578092v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.16.4228"},{"key":"2024020302450426000_2024.01.30.578092v1.20","doi-asserted-by":"publisher","DOI":"10.3390\/v6103837"},{"key":"2024020302450426000_2024.01.30.578092v1.21","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1021\/acs.jpcb.3c01759","article-title":"Elucidating residue-level determinants affecting dimerization of Ebola virus matrix protein using high-throughput site saturation mutagenesis and biophysical approaches","volume":"127","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"2024020302450426000_2024.01.30.578092v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2008.02.001"},{"key":"2024020302450426000_2024.01.30.578092v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/prot.26221"},{"key":"2024020302450426000_2024.01.30.578092v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2013.03.021"},{"key":"2024020302450426000_2024.01.30.578092v1.25","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.ILR120000753"},{"key":"2024020302450426000_2024.01.30.578092v1.26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.816280"},{"key":"2024020302450426000_2024.01.30.578092v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2012.04.022"},{"key":"2024020302450426000_2024.01.30.578092v1.28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.443960"},{"key":"2024020302450426000_2024.01.30.578092v1.29","doi-asserted-by":"crossref","first-page":"e51709","DOI":"10.15252\/embr.202051709","article-title":"Phosphatidylserine clustering by the Ebola virus matrix protein is a critical step in viral budding","volume":"23","year":"2022","journal-title":"EMBO Reports"},{"key":"2024020302450426000_2024.01.30.578092v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.24.6732"},{"key":"2024020302450426000_2024.01.30.578092v1.31","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2000.3822"},{"key":"2024020302450426000_2024.01.30.578092v1.32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.586396"},{"key":"2024020302450426000_2024.01.30.578092v1.33","doi-asserted-by":"crossref","unstructured":"Johnson, K. A. , Budicini, M. R. , Bhattarai, N. , Sharma, T. , Urata, S. , Gerstman, B. S. , et al. (2024) PI(4,5)P2 Binding Sites in the Ebola Virus Matrix Protein Modulate Assembly and Budding J. Lipid. Res. articles in press, 100512","DOI":"10.1016\/j.jlr.2024.100512"},{"key":"2024020302450426000_2024.01.30.578092v1.34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/v13071375","article-title":"Cysteine mutations in the Ebolavirus matrix protein VP40 promote phosphatidylserine binding by increasing the flexibility of a lipid-binding loop","volume":"13","year":"2021","journal-title":"Viruses"},{"key":"2024020302450426000_2024.01.30.578092v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2017.07.007"},{"key":"2024020302450426000_2024.01.30.578092v1.36","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-6-75"},{"key":"2024020302450426000_2024.01.30.578092v1.37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/fvl-2018-0162","article-title":"Structure and functions of the Ebola virus matrix protein VP40","volume":"14","year":"2019","journal-title":"Future virology"},{"key":"2024020302450426000_2024.01.30.578092v1.38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/newbio233223b0","article-title":"Protein data bank","volume":"233","year":"1971","journal-title":"Nature New Biol"},{"key":"2024020302450426000_2024.01.30.578092v1.39","first-page":"5","article-title":"Comparative protein structure modeling using Modeller","volume":"5","year":"2006","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"2024020302450426000_2024.01.30.578092v1.40","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20945"},{"key":"2024020302450426000_2024.01.30.578092v1.41","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.23702"},{"key":"2024020302450426000_2024.01.30.578092v1.42","doi-asserted-by":"publisher","DOI":"10.1042\/bj2940001"},{"key":"2024020302450426000_2024.01.30.578092v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2330"},{"key":"2024020302450426000_2024.01.30.578092v1.44","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21287"},{"key":"2024020302450426000_2024.01.30.578092v1.45","doi-asserted-by":"crossref","first-page":"044130","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","year":"2020","journal-title":"J. Chem. Phys"},{"key":"2024020302450426000_2024.01.30.578092v1.46","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20082"},{"key":"2024020302450426000_2024.01.30.578092v1.47","doi-asserted-by":"publisher","DOI":"10.1063\/1.470117"},{"key":"2024020302450426000_2024.01.30.578092v1.48","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9991(77)90098-5"},{"key":"2024020302450426000_2024.01.30.578092v1.49","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780142006"},{"key":"2024020302450426000_2024.01.30.578092v1.50","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(96)00018-5"},{"key":"2024020302450426000_2024.01.30.578092v1.51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4939-3170-5_12","article-title":"Using surface plasmon resonance to quantitatively assess lipid\u2013protein interactions","volume":"1376","year":"2016","journal-title":"Lipid Signaling Protocols"},{"key":"2024020302450426000_2024.01.30.578092v1.52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006848"},{"key":"2024020302450426000_2024.01.30.578092v1.53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03156-14"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.01.30.578092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:52:45Z","timestamp":1768456365000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.01.30.578092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":53,"URL":"https:\/\/doi.org\/10.1101\/2024.01.30.578092","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.jbc.2024.107213","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,1,31]]},"subtype":"preprint"}}